Positive Results on UCB's Vimpat
Yahoo/Zacks
Amgen, UCB halt testing of drug for fracture healing, but continue testing for osteoporosis
Yahoo/AP
UCB Reports 9M Sales Results
Yahoo/Zacks.com
Abbott: New Reasons The Split Could Tank Stock
Seeking Alpha
Submitted by moderatorj on Fri, 02/10/2012 - 18:59
Nodality, UCB Pharma ink multiyear companion diagnostics deal
FierceMedicalDevice
Otsuka Pharmaceutical and UCB focus collaboration in the area of Central Nervous System (CNS) disorders
Pipeline Review
Biotech Post-Holiday Regifting
Motley Fool
Amgen and UCB test bone loss treatment on space shuttle
Pharma Times, UK